ADMA Biologics Inc (ADMA)
6.81
+0.07
(+1.04%)
USD |
NASDAQ |
May 03, 16:00
6.80
-0.01
(-0.15%)
After-Hours: 20:00
ADMA Biologics Total Long Term Debt (Quarterly): 130.59M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 130.59M |
September 30, 2023 | 142.03M |
June 30, 2023 | 140.31M |
March 31, 2023 | 144.30M |
December 31, 2022 | 142.83M |
September 30, 2022 | 141.37M |
June 30, 2022 | 139.81M |
March 31, 2022 | 138.42M |
December 31, 2021 | 94.87M |
September 30, 2021 | 94.36M |
June 30, 2021 | 93.88M |
March 31, 2021 | 93.41M |
December 31, 2020 | 92.97M |
September 30, 2020 | 97.04M |
June 30, 2020 | 96.57M |
March 31, 2020 | 96.13M |
December 31, 2019 | 83.20M |
September 30, 2019 | 82.74M |
June 30, 2019 | 82.36M |
March 31, 2019 | 55.77M |
December 31, 2018 | 44.08M |
September 30, 2018 | 43.78M |
June 30, 2018 | 43.50M |
March 31, 2018 | 43.23M |
Date | Value |
---|---|
December 31, 2017 | 42.97M |
September 30, 2017 | 31.16M |
June 30, 2017 | 32.64M |
March 31, 2017 | 19.30M |
December 31, 2016 | 20.22M |
September 30, 2016 | 20.03M |
June 30, 2016 | 19.84M |
March 31, 2016 | 15.81M |
December 31, 2015 | 15.68M |
September 30, 2015 | 15.55M |
June 30, 2015 | 15.43M |
March 31, 2015 | 15.03M |
December 31, 2014 | 14.70M |
September 30, 2014 | 9.992M |
June 30, 2014 | 9.839M |
March 31, 2014 | 9.807M |
December 31, 2013 | 4.998M |
September 30, 2013 | 4.973M |
June 30, 2013 | 4.949M |
March 31, 2013 | 4.926M |
December 31, 2012 | 3.880M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
82.36M
Minimum
Jun 2019
144.30M
Maximum
Mar 2023
111.96M
Average
96.57M
Median
Jun 2020
Total Long Term Debt (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 0.00 |
ANI Pharmaceuticals Inc | 285.67M |
Ligand Pharmaceuticals Inc | 0.00 |
Johnson & Johnson | 33.63B |
Puma Biotechnology Inc | 99.66M |